A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid

Summary

Purpose: To decrease symptom burden, improve cognitive function, improve endurance, and decrease fatigue in subjects with post-acute sequelae of COVID-19 (PASC) or "long-hauler" COVID using amantadine. If amantadine use is determined to be efficacious in this population, the findings of this study will be used towards a subsequent randomized control trial.

Timeline

Start

2025-06

Primary completion

2025-09-01

Completion

2025-10-01

Drugs

Indications